COMMUNIQUÉS West-GlobeNewswire

Medtainer Inc. Financials update
01/05/2019
CORONA, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- The Company has received inquiries expressing concern about its failure to file its Annual Report on Form 10-K and about the date on which it will be filed. The reason [...]
GENETIC-AF Phase 2B Trial Results Published in the Journal of American College of Cardiology: Heart Failure
01/05/2019
WESTMINSTER, Colo., May 01, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Shockwave Medical to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
01/05/2019
SANTA CLARA, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
BioCorRx Inc. Unveils New UnCraveRx™ Weight Loss Program; Appoints Notable Dr. Kenneth Orbeck as Medical Director
01/05/2019
ANAHEIM, CA, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders [...]
Organogenesis Receives Innovative Technology Contract from Vizient
01/05/2019
CANTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for [...]
Novan Confirms Corporate Update Conference Call and Webcast
01/05/2019
MORRISVILLE, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN) today confirmed that the Company will host a conference call tomorrow, Thursday, May 2, 2019 at 8:15 am Eastern [...]
Nutritional High Announces Up to $3,000,000 Brokered Private Placement Financing
01/05/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, May 01, 2019 (GLOBE [...]
Matinas BioPharma Selected to Present at the BioNJ Ninth Annual BioPartnering Conference
01/05/2019
BEDMINSTER, N.J., May 01, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that Theresa Matkovits, Ph.D., Chief Development Officer [...]
Marrone Bio Innovations to Attend Upcoming Investor Conferences in May
01/05/2019
DAVIS, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced that management will attend [...]
Yield10 Bioscience to Announce First Quarter 2019 Financial Results and Host a Conference Call on Thursday, May 9, 2019
01/05/2019
WOBURN, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results
01/05/2019
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery [...]
Allogene Therapeutics Announces Expansion of Scientific Advisory Board
01/05/2019
Newly Appointed Members Include Robert Abraham, Ph.D., Malcolm K. Brenner, M.D., Ph.D., Stephen J. Forman, M.D., and Wendell Lim, Ph.D. SOUTH SAN FRANCISCO, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics [...]
L-DOS47 Phase II Randomized Study Advances to Second Cohort
01/05/2019
RICHMOND HILL, Ontario, May 01, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of [...]
Zogenix to Release First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 8
01/05/2019
EMERYVILLE, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the [...]
Tyme Technologies to Participate at the SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on May 7th
01/05/2019
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]
Jounce Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019
01/05/2019
CAMBRIDGE, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
01/05/2019
REHOVOT, Israel and NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer [...]
Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting
01/05/2019
NEW YORK and CLEVELAND, May 01, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that intravitreal administration of the Company’s [...]
VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update
01/05/2019
All four lead pipeline programs progressing towards expected clinical milestones in 2019 Gearing up for top-line data from the pivotal Phase 3 study of Sci-B-Vac®, VBI’s trivalent hepatitis B vaccine, expected mid-year [...]

Pages